Mapp Biopharmaceutical
UEI: M9V9QTHR1H28
• CAGE: 417U0
Overview
Awardee Type
Parent
Federal Capability Statement
Monoclonal antibody drug development; anti-infectives
Keywords
Monoclonal antibodies, therapeutics, anti-infectives
Website
Headquarters
San Diego, CA
United States
United States
Most Recent Award
March 20, 2024
Calculating
Federal contract and grant recipient
MAPP BIOPHARMACEUTICAL, INC.
(UEI M9V9QTHR1H28, CAGE 417U0)
is headquartered in San Diego CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in July 2003 and
federally registered in
July 2005.
Federal Award Analysis
Mapp Biopharmaceutical federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
MAPP BIOPHARMACEUTICAL, INC.
UEI
M9V9QTHR1H28
CAGE Code
417U0
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
July 9, 2003
Initial Registration
July 19, 2005
Last Registration
Feb. 13, 2024
Registration Activation
Feb. 13, 2024
Registration Expiration
Feb. 10, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Subchapter S Corporation
Subchapter S Corporation
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No
People
Vendor contacts at Mapp Biopharmaceutical
Contract Vehicles
Mapp Biopharmaceutical multi-award contract vehicles
IDV Awards
Mapp Biopharmaceutical indefinite delivery vehicle awards
Contract Awards
Mapp Biopharmaceutical prime contract awards
Grant Awards
Mapp Biopharmaceutical direct grants
Subgrant Awards
Mapp Biopharmaceutical subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Mapp Biopharmaceutical